Hydrogen peroxide induced impairment of endothelial progenitor cell viability is mediated through a FoxO3a dependant mechanism

Microvascular Research

Volumn 90, Issue , 2013, Pages 48-54

  Wang, Fei ^a   Wang, Yu Qiang ^a   Cao, Qing ^a   Zhang, Jian Jun ^b   Huang, Li Ya ^a   Sang, Tian Tian ^a   Liu, Fang ^a   Chen, Shu Yan ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; HYDROGEN PEROXIDE; TRANSCRIPTION FACTOR FKHRL1;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CAPILLARY; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; GENE SILENCING; HUMAN; HUMAN CELL; MONONUCLEAR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYDROGEN PEROXIDE; MEMBRANE PROTEINS; MUTATION; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDANTS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 84888439951     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.07.009     Document Type: Article

References (36)

1. Zampetaki A., Kirton J.P., Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc. Res. Jun 1 2008, 78(3):413-421.
2. Griese D.P., Ehsan A., Melo L.G., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts implications for cell-based vascular therapy. Circulation 2003, 108:2710-2715.
3. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
4. Kawamoto A., Gwon H.-C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001, 103:634-637.
5. Murohara T., Ikeda H., Duan J., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000, 105:1527-1536.
6. Kawamoto A., Tkebuchava T., Yamaguchi J.I., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003, 107:461-468.
7. Takahashi T., Kalka C., Masuda H., et al. Ischemia-, and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
8. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:e1-e7.
9. Werner Nikos, Nickenig Georg Influence of cardiovascular risk factors on endothelial progenitor cells limitations for therapy?. Arterioscler. Thromb. Vasc. Biol. 2006, 26:257-266.
10. Taniyama Y., Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003, 42:1075-1081.
11. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 2000, 87:840-844.
12. Touyz R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 2004, 44:248-252.
13. Dernbach E., Urbich C., Brandes R.P., et al. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004, 104:3591-3597.
14. He T., Peterson T.E., Holmuhamedov E.L., et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2021-2027.
15. Ingram D.A., Krier T.R., Mead L.E., et al. Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 2007, 25:297-304.
16. Calnan D.R., Brunet A. The FoxO code. Oncogene 2008, 27:2276-2288.
17. Puig Oscar, Mattila Jaakko Understanding forkhead box class O function: lessons from Drosophila melanogaster. Antioxid. Redox Signal. 2011, 14:635-647.
18. Zhang X.B., Tang N.M., Hadden T.J., et al. Akt, FoxO and regulation of apoptosis. Biochim. Biophys. Acta 2011, 1813:1978-1986.
19. Accili Domenico, Arden Karen C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004, 117:421-426.
20. Dijkers P.F., Medema R.H., Lammers J.W., et al. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 2000, 10:1201-1204.
21. Storz Peter Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid. Redox Signal. 2011, 14:593-605.
22. Skurk C., Maatz H., Kim H.S., et al. The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J. Biol. Chem. 2004, 279:1513-1525.
23. Chen S.Y., Wang F., Yan X.Y., et al. Autologous transplantation of EPCs encoding FGF1 gene promotes neovascularization in a porcine model of chronic myocardial ischemia. Int. J. Cardiol. 2009, 135:223-232.
24. Hur J., Yoon C.H., Kim H.S., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
25. Deschaseaux F., Selmani Z., Falcoz P.E., et al. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur. J. Pharmacol. 2007, 562:111-118.
26. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
27. Dejana E., Taddei A., Randi A.M. Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim. Biophys. Acta 2007, 1775:298-312.
28. Potente M., Urbich C., Sasaki K.I., et al. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 2005, 115:2382-2392.
29. Marchetti V., Menghini R., Rizza S., et al. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes 2006, 55:2231-2237.
30. Urbich C., Knau A., Fichtlscherer S., et al. FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J. 2005, 19:974-976.
31. Spinetti G., Cordella D., Fortunato O., et al. Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway. Circ. Res. 2013, 112(3):510-522.
32. Zhu S.K., Evans S., Yan B., et al. Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation 2008, 118:2156-2165.
33. Essafi A., Fernandez de Mattos S., Hassen Y.A., et al. Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 2005, 24:2317-2329.
34. Brunet A., Bonni A., Zigmond M.J., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
35. Medema R., Kops G., Bos J., et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000, 404:782-787.
36. Essers M.A., Weijzen S., de Vries-Smits A.M., et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 2004, 23:4802-4812.